• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

后腹腔镜肾输尿管全长切除术治疗上尿路尿路上皮癌术后膀胱内复发的危险因素分析。

Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma.

机构信息

Department of Urology, Nippon Medical School Hospital, 1-1-5, Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan.

Department of Urology, Nippon Medical School Musashikosugi Hospital, 1-396, Kosugityo, Nakahara-ku, Kawasaki city, Kanagawa, 211-8533, Japan.

出版信息

BMC Urol. 2021 Dec 2;21(1):167. doi: 10.1186/s12894-021-00932-2.

DOI:10.1186/s12894-021-00932-2
PMID:34856960
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8638342/
Abstract

BACKGROUND

One of the major concerns of patients with upper tract urothelial carcinoma (UTUC) treated with nephroureterectomy is intravesical recurrence (IVR). The purpose of the present study was to investigate the predictive risk factors for IVR after retroperitoneoscopic nephroureterectomy (RNU) for UTUC.

METHODS

Clinicopathological and surgical information were collected from the medical records of 73 patients treated with RNU for non-metastatic UTUC, without a history of or concomitant bladder cancer. The association between IVR after RNU and clinicopathological and surgery-related factors, including preoperative urine cytology and pneumoretroperitoneum time, was analyzed using the Fisher exact test.

RESULTS

During the median follow-up time of 39.1 months, 18 (24.7%) patients had subsequent IVR after RNU. The 1- and 3-year IVR-free survival rates were 85.9% and 76.5%, respectively. The Fisher exact test revealed that prolonged pneumoretroperitoneum time of ≥ 210 min was a risk factor for IVR in 1 year after RNU (p = 0.0358) and positive urine cytology was a risk factor for IVR in 3 years after RNU (p = 0.0352).

CONCLUSIONS

In UTUC, the occurrences of IVR in 1 and 3 years after RNU are highly probable when the pneumoretroperitoneum time is prolonged (≥ 210 min) and in patients with positive urine cytology, respectively. Strict follow-up after RNU is more probable recommended for these patients.

摘要

背景

接受肾输尿管切除术治疗的上尿路上皮癌(UTUC)患者主要关注的问题之一是膀胱内复发(IVR)。本研究的目的是探讨经后腹腔镜肾输尿管切除术(RNU)治疗非转移性 UTUC 后 IVR 的预测风险因素。

方法

从接受 RNU 治疗无转移性 UTUC 且无膀胱癌病史或同时性膀胱癌的 73 例患者的病历中收集临床病理和手术信息。使用 Fisher 精确检验分析 RNU 后 IVR 与临床病理和手术相关因素(包括术前尿液细胞学检查和腹膜后充气时间)之间的关系。

结果

在中位随访时间 39.1 个月期间,18 例(24.7%)患者在 RNU 后发生了随后的 IVR。1 年和 3 年的 IVR 无复发生存率分别为 85.9%和 76.5%。Fisher 精确检验显示,腹膜后充气时间延长(≥210min)是 RNU 后 1 年 IVR 的危险因素(p=0.0358),而尿液细胞学检查阳性是 RNU 后 3 年 IVR 的危险因素(p=0.0352)。

结论

在 UTUC 中,当腹膜后充气时间延长(≥210min)和尿液细胞学检查阳性时,RNU 后 1 年和 3 年发生 IVR 的可能性分别较高。建议对这些患者进行更严格的 RNU 后随访。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8da9/8638342/19e6698c5fee/12894_2021_932_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8da9/8638342/19e6698c5fee/12894_2021_932_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8da9/8638342/19e6698c5fee/12894_2021_932_Fig1_HTML.jpg

相似文献

1
Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma.后腹腔镜肾输尿管全长切除术治疗上尿路尿路上皮癌术后膀胱内复发的危险因素分析。
BMC Urol. 2021 Dec 2;21(1):167. doi: 10.1186/s12894-021-00932-2.
2
Impact of diagnostic ureteroscopy before radical nephroureterectomy on intravesical recurrence in patients with upper tract urothelial cancer.诊断性输尿管镜检查在前位根治性肾输尿管切除术对治疗上尿路尿路上皮癌患者膀胱内复发的影响。
Investig Clin Urol. 2020 Mar;61(2):158-165. doi: 10.4111/icu.2020.61.2.158. Epub 2020 Feb 4.
3
Preoperative Pyuria Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.根治性肾输尿管切除术治疗上尿路上皮癌后无膀胱癌病史患者术前脓尿预测膀胱内复发。
Clin Genitourin Cancer. 2020 Apr;18(2):e167-e173. doi: 10.1016/j.clgc.2019.09.017. Epub 2019 Sep 27.
4
The Effect of Diagnostic Ureterorenoscopy on Intravesical Recurrence in Patients Undergoing Nephroureterectomy for Primary Upper Tract Urinary Carcinoma.诊断性输尿管镜检查对上尿路尿路上皮癌患者行肾输尿管切除术后膀胱内复发的影响。
Urol Int. 2021;105(3-4):291-297. doi: 10.1159/000511650. Epub 2020 Dec 2.
5
Development and validation of a prognostic nomogram for patients with intravesical recurrence after radical nephroureterectomy for non-metastatic upper tract urothelial carcinoma.根治性肾输尿管切除术治疗非转移性上尿路上皮癌患者膀胱内复发的预后列线图的建立和验证。
World J Urol. 2020 Aug;38(8):1969-1975. doi: 10.1007/s00345-019-02985-3. Epub 2019 Oct 25.
6
Risk Factors for Intravesical Recurrence after Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Cancer (ROBUUST Collaboration).微创肾输尿管切除术治疗上尿路尿路上皮癌后膀胱内复发的危险因素(ROBUUST 协作组)。
J Urol. 2021 Sep;206(3):568-576. doi: 10.1097/JU.0000000000001786. Epub 2021 Apr 21.
7
Risk factors for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis.上尿路尿路上皮癌根治性肾输尿管切除术后膀胱内复发的危险因素:一项荟萃分析。
Urol Oncol. 2014 Oct;32(7):989-1002. doi: 10.1016/j.urolonc.2014.01.022. Epub 2014 Jul 28.
8
Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool.根治性肾输尿管切除术(RNU)后膀胱内复发的预测:临床决策工具的开发。
Eur Urol. 2014 Mar;65(3):650-8. doi: 10.1016/j.eururo.2013.09.003. Epub 2013 Sep 19.
9
Differential effect of surgical technique on intravesical recurrence after radical nephroureterectomy in patients with upper tract urothelial cancer: a systematic review and Meta-analysis.根治性肾输尿管切除术治疗上尿路上皮癌患者术后膀胱内复发的手术技术差异:系统评价和 Meta 分析。
World J Urol. 2024 Aug 20;42(1):488. doi: 10.1007/s00345-024-05185-w.
10
Predictors for Intravesical Recurrence Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A National Multicenter Analysis.上尿路尿路上皮癌根治性肾输尿管切除术后膀胱内复发的预测因素:一项全国多中心分析
Clin Genitourin Cancer. 2017 Dec;15(6):e1055-e1061. doi: 10.1016/j.clgc.2017.07.009. Epub 2017 Jul 22.

引用本文的文献

1
Effect of a Single Intravesical Instillation of Mitomycin C on the Intravesical Recurrence Rate After Ureteroscopy for Upper Tract Urothelial Carcinoma: The SINCERE Prospective Multicenter Registry Study.丝裂霉素C单次膀胱内灌注对上尿路尿路上皮癌输尿管镜检查后膀胱内复发率的影响:SINCERE前瞻性多中心注册研究
Eur Urol Open Sci. 2025 Apr 28;76:17-22. doi: 10.1016/j.euros.2025.03.017. eCollection 2025 Jun.
2
The Long-Term Functional and Oncologic Outcomes of Kidney-Sparing Surgery in Upper Tract Urothelial Carcinoma.上尿路尿路上皮癌保留肾单位手术的长期功能及肿瘤学结局
Ann Surg Oncol. 2025 Feb;32(2):1354-1363. doi: 10.1245/s10434-024-16523-y. Epub 2024 Nov 16.
3

本文引用的文献

1
The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-Analysis.上尿路尿路上皮癌诊断方式对根治性肾输尿管切除术术后膀胱内复发的影响:单中心系列研究和更新的荟萃分析。
J Urol. 2021 Sep;206(3):558-567. doi: 10.1097/JU.0000000000001834. Epub 2021 Apr 28.
2
Oncological outcomes of laparoscopic versus open nephroureterectomy for the treatment of upper tract urothelial carcinoma: an updated meta-analysis.腹腔镜与开放肾输尿管切除术治疗上尿路尿路上皮癌的肿瘤学结局:更新的荟萃分析。
World J Surg Oncol. 2021 Apr 21;19(1):129. doi: 10.1186/s12957-021-02236-z.
3
Preoperative analysis of factors associated with prolonged pneumoretroperitoneum time during retroperitoneal laparoscopic nephroureterectomy for upper tract urothelial carcinoma.
后腹腔镜肾输尿管全长切除术治疗上尿路尿路上皮癌中与气腹时间延长相关的术前因素分析。
BMC Urol. 2024 Jul 29;24(1):155. doi: 10.1186/s12894-024-01538-0.
4
Clinical Characteristics and Current Status of Treatment for Recurrent Bladder Cancer after Surgeries on Upper Tract Urothelial Carcinoma.上尿路尿路上皮癌手术后复发性膀胱癌的临床特征及治疗现状
Diagnostics (Basel). 2023 Mar 6;13(5):1004. doi: 10.3390/diagnostics13051004.
Preoperative positive voided urine cytology predicts poor clinical outcomes in patients with upper tract urothelial carcinoma undergoing nephroureterectomy.
术前尿细胞学阳性预测行肾输尿管切除术的上尿路上皮癌患者临床结局不良。
BMC Cancer. 2020 Nov 16;20(1):1113. doi: 10.1186/s12885-020-07623-5.
4
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.欧洲泌尿外科学会上尿路尿路上皮癌指南:2020 年更新版。
Eur Urol. 2021 Jan;79(1):62-79. doi: 10.1016/j.eururo.2020.05.042. Epub 2020 Jun 24.
5
Factors Associated with Prolonged Retroperitoneal Laparoscopic Radical Nephrectomy Performed by Non-expert Surgeons.与非专家外科医生施行的经腹膜后腹腔镜根治性肾切除术相关的因素。
J Nippon Med Sch. 2021 May 12;88(2):109-112. doi: 10.1272/jnms.JNMS.2021_88-302. Epub 2020 May 30.
6
Long-Term Oncologic Outcomes of Laparoscopic Versus Open Radical Nephroureterectomy for Patients with T3N0M0 Upper Tract Urothelial Carcinoma: A Multicenter Cohort Study with Adjustment by Propensity Score Matching.腹腔镜与开放性根治性肾输尿管切除术治疗 T3N0M0 上尿路尿路上皮癌患者的长期肿瘤学结果:多中心队列研究,并通过倾向评分匹配进行调整。
Ann Surg Oncol. 2019 Oct;26(11):3774-3781. doi: 10.1245/s10434-019-07623-1. Epub 2019 Jul 16.
7
Intravesical irrigation might prevent bladder recurrence in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma.膀胱内灌注可能预防上尿路上皮癌行根治性肾输尿管切除术患者的膀胱复发。
Int J Urol. 2019 Aug;26(8):791-796. doi: 10.1111/iju.14014. Epub 2019 May 12.
8
Laparoscopy versus Open Nephroureterectomy in Prognostic Outcome of Patients with Advanced Upper Tract Urothelial Cancer: A Retrospective, Multicenter, Propensity-Score Matching Analysis.腹腔镜与开放性肾输尿管切除术治疗晚期上尿路尿路上皮癌患者预后的比较:一项回顾性、多中心、倾向评分匹配分析。
Cancer Res Treat. 2019 Jul;51(3):963-972. doi: 10.4143/crt.2018.465. Epub 2018 Oct 12.
9
Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review.1973 年和 2004/2016 年世界卫生组织分级分类系统在非肌肉浸润性膀胱癌中的预后性能和可重复性:欧洲泌尿外科学会非肌肉浸润性膀胱癌指南小组系统评价。
Eur Urol. 2017 Nov;72(5):801-813. doi: 10.1016/j.eururo.2017.04.015. Epub 2017 Apr 28.
10
Prolonged pneumoperitoneum time is an independent risk factor for intravesical recurrence after laparoscopic radical nephroureterectomy in upper tract urothelial carcinoma.在上尿路尿路上皮癌腹腔镜根治性肾输尿管切除术后,气腹时间延长是膀胱内复发的独立危险因素。
Surg Oncol. 2017 Mar;26(1):73-79. doi: 10.1016/j.suronc.2017.01.003. Epub 2017 Jan 23.